• Recombinant Annexin V for Apoptosis Detection

  2026-08-25

  Brumatti, Sheridan, and Martin describe a practical bacterial-expression and purification workflow for recombinant polyhistidine-tagged annexin V, followed by FITC labeling for apoptosis analysis. The method converts phosphatidylserine exposure into a reproducible flow-cytometry or fluorescence-microscopy readout while clarifying the assay’s dependence on membrane biology and calcium-dependent binding.

• CCCP and Mitochondrial Imaging in Translational AD

  2026-08-25

  A translational framework for using CCCP as a controlled mitochondrial stressor alongside urine-derived stem cell imaging and deep learning in Alzheimer’s disease research.

• Foretinib: From Kinase Biology to Translation

  2026-08-24

  Foretinib (GSK1363089) offers translational researchers a way to interrogate coordinated Met and VEGFR signaling while separating growth arrest, cell death, motility, invasion, and metastatic behavior. This thought-leadership guide connects product pharmacology with response metrics, assay design, model selection, and evidence-driven experimental strategy.

• ATRX Loss Sensitizes Glioma Cells to RTK Inhibitors

  2026-08-24

  The reference study identified a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells were more sensitive to multi-targeted receptor tyrosine kinase and PDGFR inhibitors than comparator cells. Its combination data further indicate that RTK inhibition with Temozolomide may produce pronounced toxicity in ATRX-deficient models, supporting ATRX status as an important variable in glioma drug studies and clinical-trial interpretation.

• Resazurin Cell Viability Assay Kit for Bone Research

  2026-08-23

  Use the Resazurin Cell Viability Assay Kit to distinguish treatment-related loss of cell health from genuine changes in osteoblast differentiation during PORCN-inhibitor studies. Its live-cell-compatible fluorescence or colorimetric readout supports sensitive, scalable screening before ALP, mineralization, gene-expression, and mechanobiology endpoints.

• Benzyl-activated Streptavidin Magnetic Beads K1301

  2026-08-22

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnet-assisted capture of biotinylated proteins, nucleic acids, peptides, antibodies, sugars, and related targets from complex samples. They are appropriate for controlled purification, immunoprecipitation, interaction assays, and screening workflows, but should not be applied directly to live-cell or azide-sensitive systems without buffer exchange and compatibility testing.

• Allosteric PDK4 Inhibitors: Evidence for Compound 8c

  2026-08-22

  The reference study describes an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identifies compound 8c as a lead with nanomolar biochemical activity. Its effects in obese, allergic, and cancer-related models support PDK4 as a cross-disease metabolic target, while also highlighting the need for deeper target-engagement and translational studies.

• FAISL–FAK Proteolysis Drives TNBC Metastasis

  2026-08-21

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis, thereby enhancing triple negative breast cancer progression and metastasis. Its combination of transcriptomic discovery, mechanistic validation, and reduction-responsive siRNA delivery defines a regulatory axis with potential value for biomarker development and therapeutic research.

• (-)-Blebbistatin and Cellular Force Signaling

  2026-08-20

  A translational framework for using (-)-Blebbistatin to separate actomyosin-generated force from ligand-independent GABAB receptor activation, with practical guidance for mechanobiology, astrocyte, cardiac, and developmental studies.

• PAD4-IN-2 TFA: Tumor-Targeted NET Research

  2026-08-20

  PAD4-IN-2 TFA, also called Compound 5i TFA, combines PAD4 inhibition with meta-phenylboronic acid targeting to investigate tumor-associated neutrophils, NET biology, and metastasis. This workflow-focused guide covers uptake validation, H3cit measurement, migration assays, immune profiling, formulation, and troubleshooting.

• Ran Lactylation Links Lactate to Astrocyte Polarization

  2026-08-19

  The reference study identifies Ran lactylation at lysine 123 as a non-histone mechanism connecting lactate accumulation with STAT3 nuclear transport and A2-like astrocyte polarization after oxygen-glucose deprivation/reoxygenation. Its combination of metabolic manipulation, lactylome analysis, genetic perturbation, and spinal cord injury models provides a framework for testing SIRT1-dependent metabolic-epigenetic signaling in CNS repair.

• Dual SMAD–Wnt Inhibition for iPSC-Derived RGCs

  2026-08-19

  Chavali and colleagues developed a chemically defined, non-genetic strategy that combines dual SMAD and canonical Wnt inhibition to generate retinal ganglion cells from induced pluripotent stem cells with improved efficiency and reproducibility. The approach produced cultures exceeding 80% RGC purity and enabled magnetic enrichment to nearly 95%, providing a practical foundation for glaucoma modeling and mechanistic studies.

• Carvedilol Phosphate: A Mechanistic IRI Tool

  2026-08-18

  Carvedilol Phosphate can serve as a controlled non-selective beta blocker perturbation in cardiovascular and hepatic ischemia–reperfusion studies. This article connects compound handling with the Arrb2–6-ketoLCA hepatocyte–macrophage axis while distinguishing established evidence from testable experimental hypotheses.

• LG 101506: Practical RXR Modulator Workflows

  2026-08-18

  LG 101506 is a research-ready RXR modulator for connecting nuclear receptor activity with transcriptional, differentiation, and metabolism-focused assays. This workflow-centered guide shows how to prepare, dose, validate, and troubleshoot the compound while using TNBC checkpoint biology as a disciplined translational framework rather than an unsupported efficacy claim.

• Hoechst 33342/PI Kit for Cell Death

  2026-08-17

  Learn how the Hoechst 33342/PI Double Staining Kit converts nuclear morphology and membrane integrity into an interpretable cell-death profile. This article connects Hoechst 33342 propidium iodide staining with mechanistic research on esculin-treated renal cell carcinoma while clarifying assay limitations and complementary validation methods.

7856 records 1/524 page Next 12345 下5页 Last page